Status:
RECRUITING
MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response
Lead Sponsor:
Nantes University Hospital
Conditions:
ADHD-add
Eligibility:
All Genders
15-99 years
Phase:
NA
Brief Summary
MEthylphenidate in ADHD - Addiction(s) comorbidity: benefit of adding a cognitive remediation program to improve short- and medium-term therapeutic response
Detailed Description
It seems essential to optimize the therapeutic management of patients suffering from ADHD/addiction(s) comorbidity by specifically targeting their neuropsychological deficits, in addition to the pharm...
Eligibility Criteria
Inclusion
- Age over 15 (patients treated in the "adult" stream);
- Diagnosis of ADHD confirmed by DIVA-5 interview (for patients over 18) or Young DIVA-5 (for patients between 15 and 17) following a specialized ADHD-addiction(s) consultation;
- Indication for MPH treatment according to European recommendations (J. J. S. Kooij et al., 2019) and absence of contraindications (particularly cardiological);
- Presence of at least one comorbid addictive disorder (TUS and/or AC);
- Having given their consent to take part in the study;
- Being affiliated to the French social security system or benefiting from such a system.
Exclusion
- Presence of disorders of the higher functions or difficulties in reading or writing the French language making it impossible to collect data;
- Pregnant or breast-feeding woman;
- Person deprived of liberty;
- Person under compulsory psychiatric care;
- Participation in another interventional research protocol involving another psychotherapeutic or pharmacological intervention that may have an impact on clinical outcome;
- Guardianship or safeguard of justice.
Key Trial Info
Start Date :
December 11 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 11 2029
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT06906328
Start Date
December 11 2025
End Date
December 11 2029
Last Update
December 23 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Brest
Brest, Brittany Region, France, 29609
2
EPSM du Finistère Sud
Quimper, Brittany Region, France, 29000
3
EPSM Georges Daumézon (Fleury-les-Aubrais, Loiret)
Fleury-les-Aubrais, Centre-Val de Loire, France, 45400
4
CHRU de Tours
Tours, Centre-Val de Loire, France, 37000